"Unveiling the Link: Serotonin Receptors and Cognitive Enhancement"

A new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging has found that prucalopride, a drug that activates serotonin type 4 receptors, enhances functional connectivity between major cognitive networks in the brain. This provides a possible explanation for why drugs targeting these receptors have been shown to improve cognitive function. The findings suggest that drugs like prucalopride could be potential treatments for psychiatric conditions involving cognitive problems, such as depression. However, further research is needed to determine the effectiveness of prucalopride in individuals with depression and cognitive deficits.